Oxyhydroxyde sucroferrique contre l'hyperphosphatémie = Sucroferric oxyhydroxide for hyperphosphatemiaThe Medical letter on drugs and therapeutics (Edition française). 2014, Vol 36, Num 19, pp 90-91, issn 0253-8512, 2 p.Article

High Cut-Off Hemofiltration versus Standard Hemofiltration: A Pilot Assessment of Effects on Indices of ApoptosisATAN, Rafidah; VIRZI, Grazia M; STORR, Markus et al.Blood purification. 2014, Vol 37, Num 4, pp 296-303, issn 0253-5068, 8 p.Article

Specific Pharmacokinetic Aspects of the Urinary TractKORSTANJE, Cees; KRAUWINKEL, Walter.Handbook of experimental pharmacology. 2011, Vol 202, pp 267-282, issn 0171-2004, 16 p.Article

3D-QSAR studies on unsaturated 4-azasteroids as human 5α-reductase inhibitors: A self organizing molecular field analysis approachAGGARWAL, Saurabh; THAREJA, Suresh; BHARDWAJ, T. R et al.European journal of medicinal chemistry. 2010, Vol 45, Num 2, pp 476-481, issn 0223-5234, 6 p.Article

Ethanol extraction of Picrorhiza scrophulariiflora prevents renal injury in experimental diabetes via anti-inflammation actionLI JUAN HE; MIN LIANG; FAN FAN HOU et al.Journal of endocrinology. 2009, Vol 200, Num 3, pp 347-355, issn 0022-0795, 9 p.Article

Diuretics : From Classical Carbonic Anhydrase Inhibitors to Novel Applications of the SulfonamidesSUPURAN, Claudiu T.Current pharmaceutical design. 2008, Vol 14, Num 7, pp 641-648, issn 1381-6128, 8 p.Article

URONÉPHROLOGIE = URONEPHROLOGYLa Revue Prescrire. 2008, Vol 28, Num DEC, pp 256-265, issn 0247-7750, 10 p., SUPArticle

Therapeutic potential of vasopressin receptor antagonistsALI, Farhan; GUGLIN, Maya; VAITKEVICIUS, Peter et al.Drugs (Basel). 2007, Vol 67, Num 6, pp 847-858, issn 0012-6667, 12 p.Article

Blast from the past : The Aluminum's ghost on the lanthanum saltsCANAVESE, Caterina; MEREU, Cristina; NORDIO, Maurizio et al.Current medicinal chemistry. 2005, Vol 12, Num 14, pp 1631-1636, issn 0929-8673, 6 p.Article

Discovery and synthesis of a novel and selective drug-like P2X₁ antagonistJAIME-FIGUEROA, S; GREENHOUSE, R; PADILLA, F et al.Bioorganic & medicinal chemistry letters (Print). 2005, Vol 15, Num 13, pp 3292-3295, issn 0960-894X, 4 p.Article

Effect of indapamide on urinary calcium excretion in patients with and without urinary stone diseaseCEYLAN, Kadir; TOPAL, Cevat; ERKOC, Reha et al.The Annals of pharmacotherapy. 2005, Vol 39, Num 6, pp 1034-1038, issn 1060-0280, 5 p.Article

Improving the tolerability of anticholinergic agents in the treatment of overactive bladderDMOCHOWSKI, Roger.Drug safety. 2005, Vol 28, Num 7, pp 583-600, issn 0114-5916, 18 p.Article

Atorvastatin improves the course of ischemic acute renal failure in aging ratsSABBATINI, Massimo; PISANI, Antonio; UCCELLO, Francesco et al.Journal of the American Society of Nephrology. 2004, Vol 15, Num 4, pp 901-909, issn 1046-6673, 9 p.Article

Benefit-risk assessment of tolterodine in the treatment of overactive bladder in adultsGARELY, Alan D; BURROWS, Lara.Drug safety. 2004, Vol 27, Num 13, pp 1043-1057, issn 0114-5916, 15 p.Article

Comparative tolerability of drug treatment for nocturnal enuresis in childrenMÜLLER, Dominik; ROEHR, Charles C; EGGERT, Paul et al.Drug safety. 2004, Vol 27, Num 10, pp 717-727, issn 0114-5916, 11 p.Article

Design and synthesis of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladderPEREZ-MEDRANO, Arturo; BUCKNER, Steven A; CARROLL, William A et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 2, pp 397-400, issn 0960-894X, 4 p.Article

Food does not affect the pharmacokinetics of solifenacin, a new muscarinic receptor antagonist: results of a randomized crossover trialUCHIDA, Taisuke; KRAUWINKEL, Walter J; MULDER, Hans et al.British journal of clinical pharmacology. 2004, Vol 58, Num 1, pp 4-7, issn 0306-5251, 4 p.Article

Intravesical resiniferatoxin decreases spinal c-fos expression and increases bladder volume to reflex micturition in rats with chronic inflamed urinary bladdersDINIS, Paulo; CHARRUA, Ana; AVELINO, Antonio et al.BJU international (Papier). 2004, Vol 94, Num 1, pp 153-157, issn 1464-4096, 5 p.Article

The number, quality, and coverage of randomized controlled trials in nephrologySTRIPPOLI, Giovanni F. M; CRAIG, Jonathan C; SCHENA, Francesco P et al.Journal of the American Society of Nephrology. 2004, Vol 15, Num 2, pp 411-419, issn 1046-6673, 9 p.Article

Alfuzosine ^{(Xatral° LP 10 mg)} : Après sondage vésical pour la rétention aiguë d'urine : Un petit plus pour la reprise des mictions = Alfuzosine (Xatral® LP 10mg) : After vesical catheterism for acute urinary retention: return to voidingLa Revue Prescrire. 2004, Vol 24, Num 252, pp 493-494, issn 0247-7750, 2 p.Article

A favourable outcome using oral prednisolone and losartan only in a patient with ANCA-related glomerulonephritis: a discrepancy between histological activity and MPO-ANCANAKAHAMA, Hajime; SASAKI, Osamu; YOSHIHARA, Fumiki et al.Nephrology, dialysis, transplantation (Print). 2003, Vol 18, Num 3, pp 610-612, issn 0931-0509, 3 p.Article

Bad medicine: Low-dose dopamine in the ICUHOLMES, Cheryl L; WALLEY, Keith R.Chest. 2003, Vol 123, Num 4, pp 1266-1275, issn 0012-3692, 10 p.Article

Bradykinin reduces growth factor-induced glomerular ERK1/2 phosphorylationCELLIER, Eric; MAGE, Marilyne; DUCHENE, Johan et al.American journal of physiology. Renal physiology. 2003, Vol 53, Num 2, pp F282-F292, issn 1931-857XArticle

Changes in nocturia from medical treatment of benign prostatic hyperplasia: Secondary analysis of the Department of Veterans Affairs Cooperative Study TrialJOHNSON, Theodore M; JONES, Karen; WILLIFORD, William O et al.The Journal of urology. 2003, Vol 170, Num 1, pp 145-148, issn 0022-5347, 4 p.Article

Cyclosporine A slows the progressive renal disease of Alport syndrome (X-linked hereditary nephritis): Results from a canine modelCHEN, Dilys; JEFFERSON, Barbara; HARVEY, Scott J et al.Journal of the American Society of Nephrology. 2003, Vol 14, Num 3, pp 690-698, issn 1046-6673, 9 p.Article